Genitourinary Cancers

Technology and Bone Health Therapies
Pam Skurkay, Dianna Shafer, and Angela Hunter talk about how technology and new medicines are not only helpful for patients, but assists researchers and providers in finding more information including locating clinical trials. Read More ›

Prescribing Patterns in Low Trauma Bone Fractures

Factors Surrounding Use of Antiresportive Agents and Xgeva
Pam Skurkay talks about when providers consider prescribing one class of drugs versus another with factors that include the patient's insurance and overall health. Read More ›

Is an Injectable Antiresportive More Popular?

Increased levels of physical activity after a diagnosis of prostate cancer are associated with significantly better survival, according to the results of a new, large prospective cohort study. Read More ›

How an Injectable Became a Significant Tool In Bone Health
Pam Skurkay talks about when she and other nurses began using a medicine to treat bone-related health issues and how they eventually allowed outside medical offices the pre-authorization to use it. Read More ›

Decreasing Skeletal Issues
Dianna Shafer and Angela Hunter talk about the DEXA scan results, and how the implementation of a specific therapy helped decrease bone-related issues. Read More ›

Bone Health and Prostate Cancer
Dianna Shafer talks about how bone health goes with prostate health treatment, and trying to avoid skeletal health events. Read More ›

Immunotherapy and DEXA Scans
Pam Skurkay, Dianna Shafer, and Angela Hunter discuss the positive scan results they are seeing post-immunotherapy when using denosumab. Read More ›

Both abiraterone and enzalutamide are approved by the US Food and Drug Administration for the treatment of metastatic castration-resistant prostate cancer (mCRPC). Both drugs have different mechanisms of action and different adverse event profiles, but there are limited data comparing them directly. Read More ›

Page 2 of 6

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive: